Founded in 2016, SINGMED is committed to the design, R&D, and manufacturing of complex drug delivery devices, as well as the development of drug-device combination products. It is also committed to empowering the clinical efficacy of drug delivery, providing Chinese physicians and patients with more high-quality and affordable treatment options. Relying on its technology platforms such as pulmonary drug delivery and nasal drug delivery, SINGMED has developed single-dose capsule DPI devices, multi-dose blister DPI devices, soft mist inhalation devices and multi-dynamic nasal spray devices. Applications for these devices include the delivery of drugs for diseases such as Asthma, Chronic Obstructive Pulmonary Disease (COPD), nasal and brain disorders.
- Founded in Oct 2016
- Build R&D team and Clean Room ISO 8 pilot workshop
- Developed Generic HandiHaler®
- Developed Generic Breezhaler®;
- R&D team expansion
- Developed Generic Diskus®
- Developed Generic Respimat® Soft Mist Inhaler
- Developed innovative Dual-Power aqueous nasal spray device
- More portfolio with technical development
- Generic HandiHaler® device with China;s leading pharmaceutical company to pass NMPA official Bioequivalence(Spiriva® HandiHaler® from Boehringer)
- Generic Soft Mist Inhaler(SMI) by China;s leading pharmaceutical company with Boehringer Ingelheim medication cartridge to pass Bioequivalence
- Generic Diskus® device with China;s leading pharmaceutical company to pass NMPA official Bioequivalence(Anoro® Ellipta® Inhaler(GSK);
- Series A of financing by CREACION
- Rapidly expand team and operation capacity
- More inhalation and nasal device portfolio
- Active Primary Packaging
- Bought 26,700 ㎡ land for R&D and manufacturing centre in Changshu.
- Open Shanghai sales office
